A new generation of biosensor technology has made possible the immediate, label-free electrical detection of specific biomolecules with great precision and at low cost. Pathogens such as viruses, bacteria and fungi can be accurately and rapidly detect with a handy, easy-to-use handheld device. No laboratory, no technicians, no refrigeration, no sample preparation needed. A general-purpose device uses swappable cartridges to detect specific pathogens in samples of blood or other biofluids. Results are displayed immediately using a smartphone app.
This technology forms the basis for new, cost-effective, rapid point-of-care diagnostic assays for infectious diseases such as Zika, Ebola and pandemic influenza.
Dr. Nader Pourmand of UC Santa Cruz and Dr. Lisa Diamond, UCSF will discuss this technology. Pinpoint Science is working to commercialize this technology, based on the functionalized nanopipettes develop by Dr. Pourmand. An early-stage startup, Pinpoint is working with Dr. Pourmand to explore proof-of-concept applications that address current threats to global public health.
For more information about the presentation, contact Kyle Daniels.